Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 3,501–3,525 of 27,380 studies, newest first · page 141 of 1096.

August 2025 25

  1. 2025-08-07

    Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA

    ✓ Peer-reviewed Treatments Science (New York, N.Y.)

    Key finding: Taken together, ATV cisLALA has the potential to improve the next generation of Aβ immunotherapy through enhanced biodistribution mediated by transport across the blood-brain barrier.

  2. 2025-08-07

    Nanocarrier-based drug delivery for mild cognitive impairment: Extracellular vesicles and carbon nanotubes as emerging therapeutic tools

    ✓ Peer-reviewed Mild cognitive impairment Biomedicine & Pharmacotherapy

    Key finding: As MCI becomes increasingly prevalent in aging populations, there is an urgent need for innovative, targeted strategies to slow its progression. +4 more findings

  3. 2025-08-07
  4. 2025-08-07

    Social isolation and loneliness as modifiable risk factors for dementia: Evidence-based interventions and public health implications

    ✓ Peer-reviewed Risk factors Advanced Neurology

    Key finding: Social isolation and loneliness have emerged as significant and modifiable risk factors for dementia, especially in older adults. +1 more finding

  5. 2025-08-07

    Racial disparities in the association of epigenetic age acceleration with the transition between normal cognition, mild cognitive impairment and dementia

    ✓ Peer-reviewed Disparities Global Transitions

    Key finding: Exposure to accelerated epigenetic aging was significantly associated with a higher risk of transition from NC to MCI as well as progression from MCI to dementia. +4 more findings

  6. 2025-08-07
  7. 2025-08-07
  8. 2025-08-07

    MIND Diet and Hippocampal Sclerosis Among Community-Based Older Adults

    ✓ Peer-reviewed Genetics JAMA Network Open

    Key finding: Among 809 participants (mean [SD] age at death, 91.3 [6.1] years; 538 [72%] female; mean [SD] follow-up, 7.2 [4.4] years), HS was present in 82 (10.1%) participants; 71 participants (9%) had both HS and LATE-NC, and in the scored subset, 43 participants (14%) had moderate and 35 participants (12%) had severe hippocampal neuronal loss. +4 more findings

  9. 2025-08-07

    A comprehensive review on novel opportunities for Alzheimer therapy by targeting BIN1

    ✓ Peer-reviewed Genetics Egyptian Journal of Medical Human Genetics

    Key finding: Research revealed a significant locus of susceptibility for LOAD on the Bridging Integrator 1 (BIN1) that is situated on chromosome 2q14.3 and is identified at the time of the most significant susceptibility gene of LOAD. +1 more finding

  10. 2025-08-06

    Contributions of pharmaceutical interventions to the multidisciplinary dysphagia team: A retrospective observational study

    ✓ Peer-reviewed Health systems and care delivery Journal of pharmaceutical health care and sciences

    Key finding: This study aimed to validate these findings through a clinical examination of pharmaceutical interventions performed by a multidisciplinary dysphagia team. +2 more findings

  11. 2025-08-06

    Unravelling the genetic architecture of cerebral small vessel disease in the context of stroke

    ✓ Peer-reviewed Vascular contributions Journal of Cerebral Blood Flow & Metabolism

    Key finding: Despite significant progress through large-scale genome-wide association studies (GWAS) for cSVD and stroke, the genetic architecture underlying these conditions remains poorly understood.

  12. 2025-08-06

    Retinal vascular reactivity is associated with white matter hyperintensities and dysfunctional cerebrovascular reactivity in cerebral small vessel disease

    ✓ Peer-reviewed Vascular contributions Journal of Cerebral Blood Flow & Metabolism

    Key finding: Participants had retinal photographs and magnetic resonance brain imaging (MRI) before and during inhalation of 6% CO 2 in air. +4 more findings

  13. 2025-08-06

    Development and Validation of the End‐of‐Life Assessment Tool for Advanced Dementia: A Multi Method Study

    ✓ Peer-reviewed End-of-life care Journal of Advanced Nursing

    Key finding: The item-bank included 180 symptoms, most of which focus group nurses (n = 17) identified as occurring in advanced dementia. +4 more findings

  14. 2025-08-06
  15. 2025-08-06

    Effect of aspirin use on conversion risk from mild cognitive impairment to Alzheimer’s disease

    ✓ Peer-reviewed Mild cognitive impairment Frontiers in Aging Neuroscience

    Key finding: The data of 508,107 individuals were analyzed (mean [standard deviation] age, 67.6 [10.7] years; 66.8% women and 33.2% men), and 39,318 developed Alzheimer's disease (22,572 controls and 16,746 using aspirin). +4 more findings

  16. 2025-08-06

    Multi-omics profiling reveals two distinct trajectories in the progression from mild cognitive impairment to Alzheimer's disease

    ✓ Peer-reviewed Mild cognitive impairment Journal of Alzheimer s Disease

    Key finding: BackgroundAlzheimer's disease (AD) exhibits significant clinical and pathological heterogeneity, particularly during the mild cognitive impairment (MCI) transitional stage.

  17. 2025-08-06

    Health Awareness and Dementia Risk Among Older Adults with Hypertension and Diabetes: A Cross-sectional Study in Thailand

    ✓ Peer-reviewed Risk factors Iranian Journal of Psychiatry and Behavioral Sciences

    Key finding: Participants exhibited strong awareness of the risks associated with complications and the severity of chronic diseases. +4 more findings

  18. 2025-08-06
  19. 2025-08-06

    Utility of combination of Mini-Mental State Examination and Montreal Cognitive Assessment to predict incident Alzheimer's disease dementia in patients at high vascular risks

    ✓ Peer-reviewed Getting a diagnosis Journal of Alzheimer s Disease

    Key finding: Patients diagnosed with MCI with MMSE scores <28 or MoCA scores <26 showed a significantly higher risk of AD dementia than those with normal MMSE or MoCA groups. +1 more finding

  20. 2025-08-05

    Portable platform for measuring amyloid beta 42/40 ratio via photooxidation-induced fluorescence amplification

    ✓ Peer-reviewed Biomarkers Lab on a chip

    Key finding: By measuring 38 cases of subjective cognitive decline (SCD), 24 cases of amnestic mild cognitive impairment (aMCI), and 46 cases of AD dementia samples, we observed a significant difference in Aβ 42/40 ratios between the SCD and aMCI groups. +1 more finding

  21. 2025-08-05
  22. 2025-08-05
  23. 2025-08-05

    ApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease

    ✓ Peer-reviewed Disease mechanisms The Journal of Experimental Medicine

    Key finding: While much of the research has focused on Aβ, tau-mediated neurodegeneration is more closely associated with synaptic loss and cognitive decline in AD, emphasizing the need for a deeper understanding of tau pathology. +1 more finding

  24. 2025-08-05

    Adaptive immunity in the neuroinflammation of Alzheimer’s disease

    ✓ Peer-reviewed Inflammation and the immune system Chinese Medical Journal

    Key finding: Alzheimer's disease (AD) is the most common cause of dementia and is a growing public health challenge. +4 more findings

  25. 2025-08-05

    Association of sugar intake with incident dementia in the UK Biobank: a prospective cohort study

    ✓ Peer-reviewed Long-term cohort studies The Journal of Prevention of Alzheimer s Disease

    Key finding: Higher intakes of total sugar (HR = 1.292, 95 % CI = 1.148--1.453) and free sugar intake (HR = 1.254, 95 % CI = 1.117--1.408) were significantly associated with increased dementia risk. +3 more findings

Browse the library by subject, with the full score breakdown →